VAERS Explorer
Back to explore

Report #2866096

Received Oct 15, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
10 yrs
State
IN
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HPV9HPV (GARDASIL 9)MERCK & CO. INC.1——

Symptoms (2)

Inappropriate schedule of product administrationNo adverse event

Symptom narrative

a patient who received her first dose of GARDASIL 9 in 2022 at 10 years old and is now requesting her second dose.; No clinical side effects noted. No additional AE; This spontaneous report was received from a Nurse and refers to an approximately 13-year-old female patient. The patient's concurrent conditions, medical history, previous drug reactions, drug allergies and concomitant therapies were not reported. In 2022 (At the age of 10-year-old), the patient was vaccinated with the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL®9) (route of administration, site of administration, lot #, and expiration date were not provided) as prophylaxis; and at the reporting time, she was requesting her second dose (Inappropriate schedule of product administration). No clinical side effects noted. No additional adverse event (AE). Batch/Lot number is being requested and will be submitted if received.